Pfizer announces lung cancer awareness campaign

Ads

For the benefit of patients and all Moroccans

To mark Lung Cancer Awareness Month for the benefit of patients and the entire community, Pfizer launched its month-long awareness campaign in Morocco on Wednesday.

Lung cancer is the one that causes the most deaths in Morocco. Pfizer’s campaign aims to support patients by educating them about the early diagnosis, treatment options, and advancements in non-small cell lung cancer (NSCLC), to improve patient outcomes, increase biomarker testing and reduce high mortality rates. Mohamed Okasha, Head of Oncology Therapeutic Area at Pfizer Africa-Middle East, commented: “A patient-centered approach is at the heart of our work.

We are determined to stay at the forefront of the fight against lung cancer by forging alliances with leading researchers, healthcare professionals, government institutions, and patient groups to improve outcomes. results for the latter. Although early diagnosis is crucial and improves outcomes, testing for genetic abnormalities has also played an important role in disease control in recent years, as it offers valuable information that helps in decision-making about treatments.”

Pfizer has also reaffirmed its commitment to raising awareness of the dangers of smoking through national campaigns and investing in smoking cessation clinics that help patients, as data shows smoking remains the leading cause of lung cancer in the region.